Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading CBIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.05%70.441.0%$913.37m
AMGNAmgen Inc.
1.52%179.220.8%$649.02m
BIIBBiogen Inc.
1.55%293.080.9%$502.16m
CELGCelgene Corporation
0.60%124.251.0%$501.03m
INCYIncyte Corporation
1.39%134.952.3%$450.70m
REGNRegeneron Pharmaceuticals, Inc.
1.40%378.751.9%$338.81m
ALXNAlexion Pharmaceuticals, Inc.
1.51%133.232.0%$303.80m
TSROTESARO, Inc.
-3.98%180.8715.3%$161.32m
ILMNIllumina, Inc.
1.12%169.273.9%$158.74m
EXELExelixis, Inc.
3.99%22.395.5%$140.89m
VRTXVertex Pharmaceuticals Incorporated
0.42%91.002.6%$140.36m
CLVSClovis Oncology, Inc.
2.94%59.5116.4%$119.33m
BMRNBioMarin Pharmaceutical Inc.
0.44%94.343.9%$109.20m
AAgilent Technologies, Inc.
1.25%51.941.7%$107.79m
ACADACADIA Pharmaceuticals Inc.
-3.33%36.8419.0%$93.87m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on creating and developing novel medicines to address serious medical conditions for patients who need new or better treatment options. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.